icon-    folder.gif   Conference Reports for NATAP  
 
  20th Conference on Retroviruses and
Opportunistic Infections
Atlanta, GA March 3 - 6, 2013
Back grey_arrow_rt.gif
 
 
 
Telaprevir, Peginterferon and Ribavirin Combination Therapy for Chronic HCV Genotype 1 in HCV/HIV Co-infected Patients: Early Response and Viral Resistance
 
 
  Reported by Jules Levin
CROI 2013 March 3-6 Atlanta
 
Kenneth E. Sherman,1 Doug J. Bartels,2 Mohammad Bsharat,2 Raymond A. Rubin,2 Tara L. Kieffer,2 Mark S. Sulkowski3
1University of Cincinnati College of Medicine, Cincinnati, OH, USA; 2Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 3Johns Hopkins University School of Medicine, Baltimore, MD, USA

CROI1.gif

CROI2.gif

CROI3.gif

CROI4.gif

CROI5.gif

CROI6.gif

CROI7.gif